Stis

The CDC issued a health alert in June regarding the increased risk for dengue infection in the U.S., with suspected cases having more than doubled compared with the same time period from the previous year.

In June, the CDC began recommending doxycycline post-exposure prophylaxis — or doxy-PEP, as it is commonly known — as a prevention strategy for STIs in certain high-risk populations.

Researchers found that lenacapavir, an investigational long-acting antiretroviral drug, prevented 100% of new HIV infections among cisgender women in Africa who received injections every 26 weeks.

Testing HIV PrEP users for STIs every 6 months did not increase the risk for STIs compared with testing them every 3 months and could reduce the cost of PrEP programs, according to a study.

During a recent 5-year period, incident bacterial sexually transmitted infections increased among HIV-infected men who have sex with men regardless of virologic control, according to a recent study.

Only one-fifth of sexually active high school students reported receiving STI testing within the previous year, a survey found.

The absolute incidence and disability-adjusted life-years for STIs increased globally over 2 decades, especially in sub-Saharan Africa and Latin America, according to a recently published study.

An Australian study demonstrated that STI rates among men who have sex with men were high and increasing before they started taking PrEP and remained stable afterward.